LBF232nnPG02: Difference between revisions
No edit summary |
No edit summary |
||
Line 11: | Line 11: | ||
|Chemical Synthesis= | |Chemical Synthesis= | ||
|Metabolism= | |Metabolism= | ||
|Biological Activity=17-phenyl trinor Prostaglandin | |Biological Activity=17-phenyl trinor Prostaglandin F2 alpha reduces the intraocular pressure in the cat eye.[[Reference:Yokotani_K:Nishihara_M:Murakami_Y:Hasegawa_T:Okuma_Y:Osumi_Y:,Br. J. Pharmacol.,1995,115,672|{{RelationTable/GetFirstAuthor|Reference:Yokotani_K:Nishihara_M:Murakami_Y:Hasegawa_T:Okuma_Y:Osumi_Y:,Br. J. Pharmacol.,1995,115,672}}]] | ||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} |
Revision as of 14:00, 19 February 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1763 |
LipidMaps | LMFA03010081 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF232nnPG02 |
17-phenyl trinor Prostaglandin F_2α | |
---|---|
Structural Information | |
9α,11α,15S-trihydroxy-17-phenyl-18,19,20-trinor-prosta-5Z,13E-dien-1-oic acid | |
| |
Formula | C23H32O5 |
Exact Mass | 388.224974134 |
Average Mass | 388.49718 |
SMILES | C(c(c2)cccc2)C[C@@H](C=C[C@H]([C@H]1CC=CCCCC(O)=O)[C@@H](C[C@H](O)1)O)O |
Physicochemical Information | |
17-phenyl trinor Prostaglandin F2 alpha reduces the intraocular pressure in the cat eye. Yokotani_K et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|